Zymeworks Inc expected to post a loss of 47 cents a share - Earnings Preview

Zymeworks

04/11/2023 02:37

* Zymeworks Inc  ZYME.OQ   ZYME.O  is expected to show a
rise in
quarterly revenue when it reports  results 
    * The Middletown Delaware-based  company is expected to
report  a
286.5% increase in revenue to $10.17 million from $2.63 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Zymeworks Inc is
for a
loss of 47 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Zymeworks
Inc is
$13​, above​ its last closing price of $7.43. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.49       -0.47      -0.76     Missed  -61.6
 Mar. 31 2023  -0.55       -0.54      -0.36     Beat    32.9
 Dec. 31 2022  4.44        4.84       4.65      Missed  -3.9​
 Sep. 30 2022  -0.91       -0.92      -0.72     Beat    21.8
 ​​Jun.        -0.94       -0.96      -0.97     Missed  -0.7
 30 2022                                                
 Mar. 31 2022  -1.37       -1.67      -1.03     Beat    38.2​
 Dec. 31 2021  -1.12       -1.14      -0.76     Beat    33.4
 Sep. 30 2021  -1.09       -1.17      -1.17     Met     -0.3
 This summary was machine generated November 4 at 02:37 GMT.  All
figures in US dollars  unless otherwise stated